Annotation Detail

Information
Associated Genes
DNMT3A
Associated Variants
DNMT3A R882
DNMT3A R882
Associated Disease
acute myeloid leukemia
Source Database
CIViC Evidence
Description
In a large cohort (n=1770) of AML patients (18-60 years old), DNMT3A mutation status (65.4% of which were R882) had no prognostic value for overall, relapse free and event free survival. This was true for cytogenetically normal AML and the entire cohort.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/50
Gene URL
https://civic.genome.wustl.edu/links/genes/18
Variant URL
https://civic.genome.wustl.edu/links/variants/32
Rating
3
Evidence Type
Prognostic
Disease
Acute Myeloid Leukemia
Evidence Direction
Does Not Support
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
23632886
Drugs